← Back to Patent Explorer
US4780210A Expired / Lapsed US ⏱️ 0.0 years remaining

Tangential flow affinity ultrafiltration

Assignee: Canada, AS REPRESENTED BY MINISTER OF NATIONAL DEFENCE
•
Filing: 1987-01-07
•
Granted: 1988-10-25
•
Expires: 2007-01-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Biological macromolecules are separated from liquid mixtures in which they are contained, in substantially pure form, by a process involving tangential flow ultrafiltration of the liquid mixture in the presence of an affinity gel which binds selectively to the biological macromolecule to be recovered in pure form, in either the positive affinity absorption mode or the negative affinity absorption mode. Thus a mixture containing the biological macromolecule of interest, such as hemoglobin or (oxy)hemoglobin is first mixed with an affinity gel, such as agarose-ATP, which selectively binds to the hemoglobin or (oxy)hemoglobin and then the liquid is subjected to tangential flow ultrafiltration, so that all components of the mixture except the gel-bond hemoglobin pass through the filter. In a second stage, the gel-bond hemoglobin is treated with a salt solution to displace the hemoglobin from the gel, and then the mixture is passed again over a tangential flow ultrafiltration membrance, so that the pure hemoglobin is separated from the gel, and collected in filtrate. The affinity gel which remains in retentate can then be regenerated and re-used.

Inventors

  • 👤 Jen-Chang Hsia

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-10 01:57
CPC Classifications
C; C07; C07K; C07K1/00; C07K1/14; C07K1/34; C07K14/00; C07K14/795; C07K14/805

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 90 words
A process of separating a first biological macromolecule from a second biological macromolecule which comprises treating a mixture containing both of said first and second biological macromolecules with a macromolecular affinity substance having ligands which endow biological binding specificity to one of said first and second macromolecules but not to the other thereof, and subsequently subjecting the mixture containing the affinity substance-bound macromolecules to tangential flow ultrafiltration, so as to obtain affinity substance-bound macromolecules in the retentate of said ultrafiltration and non-affinity substance-bound macromolecules in the filtrate of said ultrafiltration.
Claim 2
Dependent Claim 90 words
A process of separating a first biological macromolecule from a second biological macromolecule which comprises treating a mixture containing both of said first and second biological macromolecules with a macromolecular affinity substance having ligands which endow biological binding specificity to one of said first and second macromolecules but not to the other thereof, and subsequently subjecting the mixture containing the affinity substance-bound macromolecules to tangential flow ultrafiltration, so as to obtain affinity substance-bound macromolecules in the retentate of said ultrafiltration and non-affinity substance-bound macromolecules in the filtrate of said ultrafiltration.
Claim 3
Dependent Claim 23 words
The process of claim 1 wherein one of said first biological macromolecule and said second biological macromolecule is hemoglobin or a derivative thereof.
Claim 4
Dependent Claim 32 words
The process of claim 2 wherein the affinity gel is an agarose gel having a selective affinity binding anion attached thereto through a space or chemical group of at least 5 angstroms.
Claim 5
Dependent Claim 36 words
The process of claim 3 wherein the selective affinity binding anion is an organic phosphate, a nucleic acid phosphate, an inositol phosphate, a carbohydrate phosphate, a carbohydrate sulfate, a carbohydrate monocarboxylate, a carbohydrate polycarboxylate or diphosphoglycerate.
Claim 6
Dependent Claim 52 words
The process of claim 1 wherein, subsequent to the tangential flow ultrafiltration, the affinity-substance-bound macromolecules in the retentate are chemically displaced from binding with the macromolecular affinity substance, and the mixture of macromolecular affinity substance and macromolecules so formed is subjected to tangential flow ultrafiltration to separate the macromolecular affinity substance therefrom.
Claim 7
Dependent Claim 31 words
The process of claim 5 wherein the macromolecular affinity substance is subsequently recycled to bind selectively to one of said first and second macromolecules from another batch of mixture containing them.
Claim 8
Dependent Claim 14 words
The process of 1 wherein the macromolecular affinity substance is an affinity chromatographic gel.
Claim 9
Dependent Claim 14 words
The process of 1 wherein the macromolecular affinity substance is an affinity chromatographic gel.
Claim 10
Dependent Claim 17 words
The process of claim 7 wherein the affinity gel is an agarose gel or a silica gel.
Claim 11
Dependent Claim 17 words
The process of claim 8 wherein said first and second biological macromolecules are hemoglobin and hemoglobin derivatives.
Claim 12
Dependent Claim 18 words
The process of claim 8 wherein the first and second biological macromolecules are a glycoprotein and a non-glycoprotein.
Claim 13
Dependent Claim 14 words
The process of claim 10 wherein the affinity gel is agarose bound to concanavalin-A.
Claim 14
Dependent Claim 16 words
The process of claim 1 wherein the macromolecular affinity substance is a soluble ligand-binding macromolecular substance.
Claim 15
Dependent Claim 17 words
The process of claim 1 wherein said first and second biological macromolecules are hemoglobin and hemoglobin derivatives.
Claim 16
Dependent Claim 19 words
The process of claim 1 wherein one of said first biological macromolecule and said second biological macromolecule is oxyhemoglobin.

References Cited (Backward Citations)

US4089778A Cited
US4579662A Cited
US4438032A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-10-25 1992-04-25 1992-10-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-10-25 1996-04-25 1996-10-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-10-25 2000-04-25 2000-10-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag